Acumen Pharmaceuticals Inc (NASDAQ:ABOS)
| 2.64 Delayed Data As of Dec 01 |  +0.24 / +10.00%Today’s Change | 1.81 Today|||52-Week Range 11.31 | -51.11% Year-to-Date |
Latest ABOS News | Press Releases
No recent news for Acumen Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.40 |
| Today’s open | 2.39 |
| Day’s range | 2.39 - 2.65 |
| Volume | 24,300 |
| Average volume (3 months) | 488,018 |
| Market cap | $135.5M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +57.54% |
| Earnings growth (this year) | -25.31% |
| Earnings growth (next 5 years) | -24.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.51 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 25, 2024 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$42.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
